PharmaLegacy
Shanghai, China pharmalegacy.com From their website, Nov 2026
- GLP
- AAALAC
Work here? Claim this listing
About
PharmaLegacy is a preclinical CRO that provides in vitro and in vivo drug development services for pharmaceutical clients. It works across discovery, candidate screening, IND support, non-human primate studies, histopathology, biomarker work, and medical device testing. The company has operations in Shanghai, China and San Diego, California.
Services
In Vitro Efficacy and Safety Testing
Provides systematic in vitro assays and screens for efficacy and safety, including kinase, cell-based, ADC, vaccine, and flow cytometry work.
Kinase/Enzyme Assays
Runs high-throughput kinase and enzyme assays for kinome screening and compound selectivity evaluation.
BaF3 Assays
Uses BaF3 cell proliferation assays to study kinase inhibitor potency and cellular growth mechanisms.
GPCR Assays
Performs GPCR-based assays as part of in vitro screening and characterization services.
Cell-based Assays – Cytotoxicity
Measures cytotoxic effects in cell-based formats.
Cell-based Assays – Immune Modulator
Supports immune-modulator evaluation in cell-based assay formats.
Cell Based Assays – Immuno-Oncology
Provides cell-based assays for immuno-oncology research and screening.
ADC In Vitro Evaluation
Evaluates antibody-drug conjugates in vitro.
22 more services
- Vaccine Evaluation
- Cell Differentiation / Polarization Assay
- Flow Cytometry / FACS
- Safety Assays
- Biomarkers and Pharmacodynamics Analysis
- DMPK
- ADME
- PK
- Toxicology
- Bioanalysis
- Pharmacokinetics and Pharmacodynamics (PK/PD)
- Candidate Screening / IND package
- Non-Human Primate Studies
- NHP Models of Inflammation and Immune Diseases
- Histopathology
- Histomorphometry
- Biomarker Discovery & Detection
- In Vitro Immunization
- Medical Device Testing
- Cardiovascular Devices
- Cerebrovascular Devices
- Bone / Dental Devices
Capabilities
- Assays and studies
- PK/PD
- Rodent models
- Non-human primate
- Cell-based assays
- Histopathology
- Flow cytometry
19 more
- ADCs
- Toxicology
- ADME
- Bioanalysis
- Kinase assays
- Enzyme assays
- BaF3 proliferation assays
- GPCR assays
- Cytotoxicity assays
- Immune modulator assays
- Immuno-oncology assays
- ADC in vitro evaluation
- Vaccine evaluation
- Cell differentiation assay
- Cell polarization assay
- FACS
- Biomarker analysis
- PK/PD analysis
- Safety assays
- Scale and capacity
- Over 1,500 validated models
- Over 1,500 validated animal models
- Over 400 kinases and enzymes
- More than 350 BaF3 engineering cell lines
- Over 400 pre-characterized GPCR cell lines
- 100+ indications
- 15+ average years experience of staff
- 600+ FDA / CFDA IND filings
- Therapeutic areas
- Infectious diseases
- Oncology
- Immuno-oncology
- Inflammation
- Immunity
- Autoimmunity
9 more
- Central nervous system diseases
- Neurodegenerative diseases
- Neuropsychiatric diseases
- Migraines and pain
- Metabolic disease
- Hepatic disease
- Renal disease
- Cardiovascular disease
- Pulmonology
Instruments and platforms
- Flow cytometry / FACS
- Flow cytometry
- FACS
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Vaccine
- Species and models
- Humanized mouse models
- Syngeneic mouse models
- Xenograft mouse models
- Nude rat models
- Non-human primates
- BaF3 cells
4 more
- BaF3 cell lines
- GPCR cell lines
- Human cell panel
- CDX models
Certifications
As the company states them, with the certificate or registry record where there is one.
AAALACSelf-reported
Scope: Studies
GLPSelf-reported
Details
- Type
- CRO
- Address
- 121 Longgui Road, Jinqiao Free Trade Zone, Shanghai, China 201201 PharmaLegacy Researc
- Sites
- San Diego, United States
- Serves
- North America, China, United States, international
- FDA GLP site
- PharmaLegacy Research, San Diego, US source
Public records
- GLP
- Inspected under GLP · FDA source